Skip to main content

Lorena Valero Arrese

Medical doctor in the Paediatric Oncohaematology Department.

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca
Doctor
Paediatric Oncology and Haematology
Children's Hospital and Woman's Hospital
Lorena Valero Arrese

Lorena Valero Arrese

Lorena Valero Arrese

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca
Doctor
Paediatric Oncology and Haematology
Children's Hospital and Woman's Hospital

Medical doctor in the Paediatric Oncohaematology Department.

After graduating in Medicine from the Universidad del País Vasco (UPV), I completed my residency in Pediatrics at the Virgen de las Nieves Hospital in Granada, focusing my final year of training on the field of oncohematology.

Since 2017, I have been part of the Paediatric Oncohematology Department at Vall d’Hebron University Hospital, and my main areas of interest include lymphomas, histiocytoses, endocrine tumours, central nervous system tumours, early-phase clinical trials, and the development of new therapies.

I am a member of the non-Hodgkin lymphoma and histiocytosis and haemophagocytic lymphohistiocytosis groups of the Sociedad Española de Hematología y Oncología Pediátricas (SEHOP).

Projects

Implementation and new biomarker development for Personalised Medicine for Childhood Cancers in Spain

IP: Lucas Moreno Martín-Retortillo
Collaborators: Aroa Soriano Fernández, Miguel Segura Ginard, Lorena Valero Arrese, Raquel Hladun Alvaro, Elena Antima Martinez Saez, Marta Sese Faustino, Gabriela Guillén Burrieza, Josep Roma Castanyer, Andrea Vilaplana Blanes, Estela Carrasco López, Margarita Ortega Blanco, Implementation and new biomarker development for Personalised Medicine for Childhood Cancers in Spain, Asbleidy Carolina Torres Barbosa, Berta Campos Estela
Funding agency: Instituto de Salud Carlos III
Funding: 369260
Reference: PMP21/00073
Duration: 01/01/2022 - 31/12/2025

Next generation personalised medicine for childhood cancers

IP: Lucas Moreno Martín-Retortillo
Collaborators: Aroa Soriano Fernández, Jessica Camacho Soriano, Raquel Hladun Alvaro, Gabriela Guillén Burrieza, Andrea Vilaplana Blanes, Lorena Valero Arrese, Mariona Morell Daniel
Funding agency: Instituto de Salud Carlos III
Funding: 214170
Reference: PI21/01661
Duration: 01/01/2022 - 30/06/2026

Related news

The Scientific Coordinator of ERN-EuroBloodNet will lead for one year the group that defines the common strategy of the European Reference Networks to improve care for rare and complex diseases.

Vall d’Hebron participates as a reference centre in Spain for early-phase clinical trials and coordinates the national ReALLNet network, promoting research into relapsed acute lymphoblastic leukemia.

The PHOENIX project, involving 13 European institutions, will evaluate for the first time in paediatric patients the drug ibrilatazar from AbilityPharma in a phase I/II clinical trial.

Related professionals

Laia Font Planas

Laia Font Planas

Predoctoral researcher
Liver Diseases
Read more
Xavier Merino Casabiel

Xavier Merino Casabiel

Predoctoral researcher
Molecular Imaging and Therapy
Read more
Ana Maria Casas Guerrero

Ana Maria Casas Guerrero

Research technician
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Daniel Nuñez Regueriro

Daniel Nuñez Regueriro

Coordinador/a
Technological Infrastructure Unit
Digital Transformation Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.